Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma (Q43548448)

24 November 2017

Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma (English)

1 reference

24 November 2017

1 reference

Zimmermann C

1

1 reference

24 November 2017

Ginis I

2

1 reference

24 November 2017

Furuya K

3

1 reference

24 November 2017

Klimanis D

4

1 reference

24 November 2017

Ruetzler C

5

1 reference

24 November 2017

Spatz M

6

1 reference

24 November 2017

Hallenbeck JM

7

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

24 November 2017

1 reference

24 November 2017

895

1 reference

24 November 2017

59-65

1 reference

24 November 2017

1-2

1 reference

Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

The nonspecific nature of endotoxin tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Observations on the biosynthesis of rat brain ceramide and cerebroside in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Glycosphingolipids of human plasma lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Ischemic tolerance in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

LPS pretreatment protects from hepatic ischemia/reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Cerebrovascular hemodynamics and ischemic tolerance: lipopolysaccharide-induced resistance to focal cerebral ischemia is not due to changes in severity of the initial ischemic insult, but is associated with preservation of microvascular perfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

In vivo metabolism of fluorescent ceramide in central nervous system myelin of adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Tumor Necrosis Factor-α Activates the Sphingomyelin Signal Transduction Pathway in a Cell-Free System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

TNF-alpha pretreatment prevents subsequent activation of cultured brain cells with TNF-alpha and hypoxia via ceramide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Functions of ceramide in coordinating cellular responses to stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury : possible connection to an interleukin-6-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Temporal profiles of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in the plasma and hypothalamic paraventricular nucleus after intravenous or intraperitoneal administration of lipopolysaccharide in the rat: estimation by push-pu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Ceramide metabolism in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

'Ischemic tolerance' phenomenon found in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Role of ceramide in lipopolysaccharide (LPS)-induced signaling. LPS increases ceramide rather than acting as a structural homolog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Tumor necrosis factor: a cytokine involved in toxic effects of endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Neuroprotective signal transduction: relevance to stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Quantitation of free sphingosine in liver by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Regulation of the gene encoding tumor necrosis factor alpha (TNF-alpha) in the rat brain and pituitary in response in different models of systemic immune challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

A single endotoxin challenge induces delayed myocardial protection against infarcation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Separation and Identification of Cerebrosides in Cerebrospinal Fluid by Gas Chromatography—Mass Spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Dual role of tumor necrosis factor alpha in brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Dose-dependence of bacterial lipopolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

Ischaemic preconditioning: present position and future directions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902028-5

10.1016/S0006-8993(01)02028-5

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference